⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 23, 2024Indian Journal of OphthalmologyOpen Access

Outcomes of intravitreal anti-VEGF injections and panretinal photocoagulation in preretinal hemorrhage secondary to proliferative diabetic retinopathy involving the fovea

Manpreet Brar Mansi Sharma Satinder Pal Singh Grewal Mangat Dogra

View Full Paper

Ask AI

Bookmark

Share

Abstract

To evaluate the outcome of intravitreal anti-vascular endothelial growth factor (VEGF) injections and panretinal photocoagulation (PRP) in fovea involving preretinal hemorrhage (PRH) secondary to proliferative diabetic retinopathy (PDR).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Brar et al. (2024) studied this question.

synapsesocial.com/papers/68e77f43b6db6435876f2899 https://doi.org/10.4103/ijo.ijo_2296_23

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Pan Retinal Photocoagulation VS Intravitreal Injection of Anti-VEGF in Treatment of Proliferative Diabetic RetinopathyOriginal Research · 2025
2Comparison of Intravitreal Antivascular Endothelial Growth Factor Therapy in Treatment-Naïve vs Panretinal Photocoagulation–Treated Eyes With Proliferative Diabetic RetinopathyCase Report · 2026 · 1 citations
3Initial Therapy of Panretinal Photocoagulation vs Anti-VEGF Injection for Proliferative Diabetic Retinopathy2024 · 27 citations
4Intravitreal conbercept injection with panretinal photocoagulation for high-risk proliferative diabetic retinopathy with vitreous hemorrhage2024 · 2 citations
5Does addition of intravitreal bevacizumab confer additional benefit in management of proliferative diabetic retinopathy?2024